LPV 200mg / r 50mg, tab.
                    STD
                    DORALPVR5T-
                
                Valid Article
                            Account code:
                            60000
                        
                        
                            HS Code:
                            300490
                        
                        
                            Last Updated on:
                            03/11/2025, 22:53:56
                        
                    
                Former
                    Code(s):
                     -X DORAZBD0336 DORAZBD0441 DORALPRF2T5 DORAZBD0457
                
            
            
                            
                            
                Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
            
            
                                    J05AR10
                            
                Anatomical Therapeutic Chemical Classification according to WHOCC
            
                            
                            
                Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
            
                    LOPINAVIR (LPV) / RITONAVIR (r)
Therapeutic Action
Fixed-dose combination (FDC) of two antiretrovirals, protease inhibitors (PI)
Indications
HIV infection, in combination with other antiretrovirals
Instructions for use
Granules in sachet and 100mg/25mg tablets are intended for paediatric use.
Pour the granules into a small amount of breast milk, water or soft foods and administer immediately (within 2 hours of preparation max.).
Precautions for Use
Pellets-in-a-capsule and oral solutions became non-standard according to 2021 WHO list for antiretroviral drugs for children:
- granules in sachet can be given to children from the age of two weeks (instead of three months) and are easier to administer than pellets in capsule.
 - with increasing use of integrase inhibitor–based regimens and a preference for granules, oral solution should no longer be required.
 
Storage
Below 25ºC - Protect from sunlight - Protect from humidity